Espinoza Octavio bought LGND
May 17, 2024 · Form 4 insider transaction
Espinoza Octavio bought 5,022 shares of Ligand Pharmaceuticals Incorporated at $52.84 per share, a transaction worth $265.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,022
Price
$52.84
Total value
$265.4K
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 17, 2024
Filing dateMay 17, 2024
Shares owned after28,535
OwnershipDirect
10b5-1 planNo
AmendedNo